Company / Total Assets
NOVAVAX INC Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.2B
FY2025
5-year range
$1.2B / $2.6B
FY2021-FY2025
Trend
-24.6%
vs FY2024
Sector context
#70 of 214
Health Care
What the data says
At $1.2B, NOVAVAX INC's total assets ranks #70 of 214 in the Health Care sector. Total Assets has declined for 4 consecutive years, from $2.6B in FY2021 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of -5.8%.
Declined from $1.8B to $1.2B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -19.5%
- 5-Year CAGR
- -5.8%
- 10-Year CAGR
- -
Sector benchmark
#70 of 214 in Health CareTop 33% of 214This company $1.2B Sector average $7.5B
▼
-84.2% below sector average
Key checks
Key Insights
- NOVAVAX INC's total assets has declined for 4 consecutive years.
- 5-year CAGR of -5.8%, indicating a declining trend.
- In FY2025, total assets decreased 24.6% year-over-year.
- Ranks #70 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | -24.6% |
| FY2024 | $1.6B | -13.2% |
| FY2023 | $1.8B | -20.4% |
| FY2022 | $2.3B | -12.3% |
| FY2021 | $2.6B | +62.8% |
| FY2020 | $1.6B | +815.0% |
| FY2019 | $173.0M | -16.8% |
| FY2018 | $208.0M | -31.2% |
| FY2017 | $302.5M | -23.3% |
| FY2016 | $394.3M | +2.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026